Affiliation:
1. Doctor of Business Administration Program, The Graduate School, University of Maryland Global Campus, Largo, MD 20774, United States
Abstract
Orphan drug products (e.g. drugs and biologics) in the United States are those that treat
people with rare chronic diseases, often cancer or metabolic disease. The rare disease condition
being treated by these orphan drugs must serve a patient population of less than 200,000 people in
the U.S. in order to earn the orphan drug product title. Just as the disease conditions are seen as
“orphans,” so, we assert is the thermochemical understanding of the drugs themselves in terms of
the chemical structures that define those drugs. This article illustrates this orphan thermochemical
status for a recent series of orphan drugs.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献